Inhibitor Therapeutics, Inc. (INTI)

Every official Inhibitor Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports, proxy statements, shareholding and announcements, straight from the regulator. Free to search.

Inhibitor Therapeutics, Inc. documents

• Inhibitor Therapeutics, Inc. 10-K 2026INTI 10-K 2026: annual report for fiscal 2026
• Inhibitor Therapeutics, Inc. 10-K 2025INTI 10-K 2025: annual report for fiscal 2025
• Inhibitor Therapeutics, Inc. 10-K 2024INTI 10-K 2024: annual report for fiscal 2024
• Inhibitor Therapeutics, Inc. 10-K 2023INTI 10-K 2023: annual report for fiscal 2023
• Inhibitor Therapeutics, Inc. 10-K 2022INTI 10-K 2022: annual report for fiscal 2022
• Inhibitor Therapeutics, Inc. 10-Q 2026INTI 10-Q 2026: quarterly report for fiscal 2026
• Inhibitor Therapeutics, Inc. 10-Q 2025INTI 10-Q 2025: quarterly report for fiscal 2025
• Inhibitor Therapeutics, Inc. 10-Q 2024INTI 10-Q 2024: quarterly report for fiscal 2024
• Inhibitor Therapeutics, Inc. 10-Q 2023INTI 10-Q 2023: quarterly report for fiscal 2023
• Inhibitor Therapeutics, Inc. 10-Q 2022INTI 10-Q 2022: quarterly report for fiscal 2022
• Inhibitor Therapeutics, Inc. 8-K 2026INTI 8-K 2026: current report for fiscal 2026
• Inhibitor Therapeutics, Inc. 8-K 2025INTI 8-K 2025: current report for fiscal 2025
• Inhibitor Therapeutics, Inc. 8-K 2024INTI 8-K 2024: current report for fiscal 2024
• Inhibitor Therapeutics, Inc. 8-K 2023INTI 8-K 2023: current report for fiscal 2023
• Inhibitor Therapeutics, Inc. 8-K 2022INTI 8-K 2022: current report for fiscal 2022
• Inhibitor Therapeutics, Inc. DEF 14A 2026INTI DEF 14A 2026: proxy statement for fiscal 2026
• Inhibitor Therapeutics, Inc. DEF 14A 2025INTI DEF 14A 2025: proxy statement for fiscal 2025
• Inhibitor Therapeutics, Inc. DEF 14A 2024INTI DEF 14A 2024: proxy statement for fiscal 2024
• Inhibitor Therapeutics, Inc. DEF 14A 2023INTI DEF 14A 2023: proxy statement for fiscal 2023
• Inhibitor Therapeutics, Inc. DEF 14A 2022INTI DEF 14A 2022: proxy statement for fiscal 2022
• Inhibitor Therapeutics, Inc. Form 4 2026INTI Form 4 2026: insider trading filing for fiscal 2026
• Inhibitor Therapeutics, Inc. Form 4 2025INTI Form 4 2025: insider trading filing for fiscal 2025
• Inhibitor Therapeutics, Inc. Form 4 2024INTI Form 4 2024: insider trading filing for fiscal 2024
• Inhibitor Therapeutics, Inc. Form 4 2023INTI Form 4 2023: insider trading filing for fiscal 2023
• Inhibitor Therapeutics, Inc. Form 4 2022INTI Form 4 2022: insider trading filing for fiscal 2022
• Inhibitor Therapeutics, Inc. S-1 2026INTI S-1 2026: registration statement for fiscal 2026
• Inhibitor Therapeutics, Inc. S-1 2025INTI S-1 2025: registration statement for fiscal 2025
• Inhibitor Therapeutics, Inc. S-1 2024INTI S-1 2024: registration statement for fiscal 2024
• Inhibitor Therapeutics, Inc. S-1 2023INTI S-1 2023: registration statement for fiscal 2023
• Inhibitor Therapeutics, Inc. S-1 2022INTI S-1 2022: registration statement for fiscal 2022
• Inhibitor Therapeutics, Inc. 13F 2026INTI 13F 2026: institutional holdings for fiscal 2026
• Inhibitor Therapeutics, Inc. 13F 2025INTI 13F 2025: institutional holdings for fiscal 2025
• Inhibitor Therapeutics, Inc. 13F 2024INTI 13F 2024: institutional holdings for fiscal 2024
• Inhibitor Therapeutics, Inc. 13F 2023INTI 13F 2023: institutional holdings for fiscal 2023
• Inhibitor Therapeutics, Inc. 13F 2022INTI 13F 2022: institutional holdings for fiscal 2022

More companies